CBPP October 2020 | Case-Based Peer Perspectives Spotlight Live

Awan Weighs Options for Treating a Patient With High-Risk CLL

November 15, 2020

Clinical Articles

During a Targeted Oncology Case Based Peer Perspectives event, Farrukh Awan, MD, discussed the various treatment options for a 61-year-old patient with high-risk chronic lymphocytic leukemia.

Pennell Considers Treatments in Front- and Later-Line Settings for EGFR+ NSCLC

November 08, 2020

Clinical Articles

In the treatment of EGFR-mutant non–small cell lung cancer, oncologists face multiple challenges with prescribing medications to patients. During a Targeted Oncology Case Based Peer Perspective event, Nathan Pennell, MD, PhD, discussed these challenges as well as potential treatment approaches with a group of peers.

Kulik Addresses Transplant and Therapy in HCC

November 06, 2020

Clinical Articles

Laura M. Kulik, MD, talked through diagnosing a 77-year-old female patients with hepatocellular carcinoma as well as the treatment options for her disease during a Targeted Oncology Case Based Peer Perspectives event.

Aggarwal Examines Nivolumab Plus Ipilimumab in First-Line NSCLC

November 05, 2020

Clinical Articles

The use of chemoimmunotherapy as treatment of patients with treatment-naive stage IIIB or IV nonsquamous non–small cell lung cancer was the topic of a Targeted Oncology Case Based Peer Perspective discussion led by Charu Aggarwal, MD, MPH.

Leal Discusses Therapy Selection in Oncogene-Driven Lung Cancer

November 04, 2020

Clinical Articles

A selection of therapies exist for patients with oncogene-driven lung cancer. Ticiana Leal, MD, discussed these options with a group of peers during a Targeted Oncology Case Based Peer Perspectives event.

Heymach Discusses MET Exon 14 Skipping Mutations in NSCLC

November 03, 2020

Clinical Articles

During a Targeted Oncology Case Based Peer Perspective event, John V. Heymach, MD, PhD, discussed the testing methods for non–small cell lung cancer with MET exon 14 skipping mutations. The discussion was based on the case of a 48-year-old woman.

Brander Details Different Therapies and Modalities for Treatment of CLL in the Second Line

October 29, 2020

During a Targeted Oncology Case Based Peer Perspectives event, Danielle Brander, MD, assistant professor of Medicine at Duke Cancer Institute in Durham, NC, discussed options for treating a 53-year-old female patients with chronic lymphocytic leukemia.

Burger Reviews BTK Inhibitors and Beyond in Frontline CLL

August 25, 2020

Clinical Articles

During a virtual Case Based Peer Perspectives event, Jan A. Burger, MD, PhD, discussed testing and the treatment options for chronic lymphocytic leukemia, based on a case of 71-year-old female patient.